Market Tracker

04/27 6:16am ET

Hyperion Therapeutics Inc (NASDAQ:HPTX)

45.97
Delayed Data
As of Apr 24
 -0.11 / -0.24%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.54%
Year-to-Date

Today’s Trading

Previous close46.08
Today’s open46.05
Day’s range-- - --
Volume96,553
Average volume (3 months)526,920
Market cap$955.0M
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)-138.75%
Earnings growth (this year)+349.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+169.13%
P/E ratioNM
Price/Sales4.33
Price/Book7.25

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.25-0.99%
SCMPSucampo Pharmaceutic...-0.31-1.45%
OREXOrexigen Therapeutic...-0.08-1.08%
OMEROmeros Corp-0.35-1.42%
Data as of 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.23
Annual revenue (last year)$113.6M
Annual profit (last year)-$6.3M
Net profit margin-5.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts